Taking Mounjaro alongside a beta blocker: what the evidence says

Beta blockers are not listed as contraindications to Mounjaro, but their interaction with tirzepatide requires careful prescriber review of your individual circumstances.
Beta blockers can slow heart rate and affect how the body responds to low blood sugar — relevant context when any new weight-loss medicine is added to the mix.
Mounjaro slows gastric emptying, which may alter the absorption timing of oral medicines, including beta blockers taken by mouth.
Your prescriber should be given a complete medicines list, including over-the-counter products, before any GLP-1 medicine is approved.

If you take a beta blocker for your heart or blood pressure, you may be wondering whether it is safe to use Mounjaro at the same time. The short answer is that tirzepatide and beta blockers are not known to be directly incompatible, but several practical considerations are worth understanding before starting treatment — and your prescriber needs to know about every medicine you take. Mounjaro is a prescription-only medicine licensed in the UK for weight management and type 2 diabetes; no pharmacist or doctor can approve it without reviewing your full medical and medication history first. The decision about whether it is right for you is a clinical one, and the sections below lay out the key factors involved so you can have a more informed conversation with your prescriber.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The clinical picture: beta blockers, tirzepatide, and the decisions involved

Why this combination asks more of your prescriber than a simple yes or no

Beta blockers (medicines like bisoprolol, atenolol, carvedilol and propranolol) work by blocking the effects of adrenaline on the heart. They lower heart rate and blood pressure, and they are prescribed for a range of conditions including hypertension, angina, heart failure and arrhythmias. Some people also take them for anxiety or migraine prevention.

Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist that reduces appetite, slows gastric emptying and supports significant weight loss over time. The NHS tirzepatide medicines page lists its known interactions and side effects; beta blockers are not flagged as a direct contraindication. That said, the absence of a listed contraindication is not a green light to proceed without clinical assessment, it simply means the interaction profile is more nuanced than a flat prohibition.

The real question for your prescriber is not whether the two medicines clash outright, but how they interact in your specific situation: your cardiovascular history, your current doses, how well-controlled your blood pressure is, and what effect weight loss itself is likely to have on each condition being treated. Conditions like hypertension often improve substantially as body weight falls, which can mean the dose of a beta blocker needs reviewing over time. That conversation belongs with your prescribing team, not a search engine.

You can read more about how tirzepatide works on our tirzepatide overview page.

The gastric-emptying effect and what it means for oral medicines

One genuinely practical consideration is Mounjaro's effect on gastric emptying. Tirzepatide slows the rate at which food and liquids leave the stomach. For most people, that is partly why the medicine reduces hunger, meals feel more filling for longer. But slower gastric emptying can also delay the absorption of oral medicines taken around the same time.

Most beta blockers are taken by mouth as tablets. The clinical significance of delayed absorption varies by medicine and individual, and for medicines taken once daily at consistent times the overall amount absorbed is typically unaffected over the course of a day. Even so, if you notice any change in how your beta blocker seems to be working after starting Mounjaro (unusual heart rate, changes in blood pressure, or feeling faint) that is a reason to contact your prescriber promptly rather than waiting for your next scheduled review.

A straightforward checking habit: take one minute to note your resting pulse each morning before getting out of bed. Many people do this with a phone or smartwatch, and if you want to get more from tracking your progress week to week, our guide to Mounjaro stickers covers how people use them to stay organised and motivated. If you see a consistent shift after starting tirzepatide, flag it. It may mean nothing; it may mean a dose conversation is due. Either way, your prescriber will want to know.

The BNF entry for tirzepatide contains the professional-level interactions reference your GP or pharmacist will consult.

Blood pressure, weight loss, and why your prescriber may want to review your beta blocker over time

Hypertension is one of the weight-related conditions that makes someone eligible for Mounjaro under its UK licence. It is also one of the conditions most likely to improve meaningfully as weight falls. Clinical trial data from the SURMOUNT programme showed average body-weight reductions of around 20% at the highest tirzepatide dose in adults with obesity, which often translates into measurable falls in blood pressure.

For people whose beta blocker is prescribed primarily for blood pressure control, this matters. As weight drops and blood pressure comes down naturally, the existing dose of a beta blocker might become more than the body needs. Symptoms of over-treatment can include fatigue, dizziness, cold hands and feet, or a heart rate that becomes unusually slow. None of these are reasons to stop a beta blocker abruptly, doing so without medical guidance can cause a rebound effect, particularly in people with coronary artery disease. The right path is a scheduled review with your GP or cardiologist, ideally planned before you start tirzepatide so everyone is aligned from the outset, and our page on how to lose weight quicker on Mounjaro explains the lifestyle factors that can help results come through more steadily alongside that clinical oversight.

If you are thinking about cost alongside all of this, our page on Mounjaro's UK pricing gives factual background on how the market has changed and what a private prescription typically involves.

What to tell our prescribers (and what to expect from the review

At nume, every consultation is read by a GPhC-registered Independent Prescriber) a real clinician, not an automated filter. When you complete the consultation, list every medicine you take, including your beta blocker, its dose, the condition it is treating, and whether it is prescribed by a GP or a specialist. Also mention any over-the-counter products and supplements.

Our prescribers will look at the full picture before deciding whether Mounjaro is clinically appropriate for you. If they approve treatment, they may recommend that your GP is looped in so that any blood pressure or heart-rate monitoring is coordinated. We notify your GP in line with GPhC guidance as part of our standard process, something worth knowing if you are concerned about communication between clinicians, and it is also worth reading our page on whether you get drunk quicker on Mounjaro since alcohol can affect heart rate and blood pressure in ways that are relevant when you are taking a beta blocker.

You can find practical guidance on getting the most from treatment on our page about making Mounjaro work effectively, and a broader look at the treatment landscape on our weight-loss treatments overview.

If you are ready to take the next step, start your free consultation and our prescribers will review your medicines list the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions